Suchergebnisse - "Wei, Jiacong"

PubPharm (27)

1

Corrigendum to Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery [Hum Pathol 108 (2021) 84-92

enthalten in: Human pathology | 2022

von Liu, L. | Wei, J. | Teng, F. | +8

ErratumFor: Hum Pathol. 2021 Feb;108:84-92. - PMID 33245986

2

Mesenchymal cystic hamartoma of the lung : A case report

enthalten in: Medicine | 2022

von Yuan, L. | Wang, S. | Wei, J. | +2

3

YAP1 protein expression has variant prognostic significance in small cell lung cancer (SCLC) stratified by histological subtypes

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Wang, X. | Guo, Y. | Liu, L. | +7

4

Metastatic adenocarcinoma to the breast from the lung simulates primary breast carcinoma-a clinicopathologic study

enthalten in: Translational cancer research | 2021

von Wang, X. | Luo, Y. | Liu, L. | +4

5

Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC

enthalten in: Targeted oncology | 2021

von Wei, J. | Meng, P. | Terpstra, M. | +14

6

YAP1 protein expression has variant prognostic significance in SCLC stratified by histological subtypes

enthalten in: ResearchSquare.com | 2021

von Wang, X. | Guo, Y. | Liu, L. | +7

7

YAP1 protein expression has variant prognostic significance in SCLC stratified by histological subtypes

enthalten in: ResearchSquare.com | 2021

von Wang, X. | Guo, Y. | Liu, L. | +7

8

YAP1 Protein Expression Has Variant Prognostic Significance in SCLC Stratified by Histological Subtypes

enthalten in: ResearchSquare.com | 2021

von Wang, X. | Guo, Y. | Liu, L. | +7

9

Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC

enthalten in: Targeted oncology | 2021

von Wei, J. | Meng, P. | Terpstra, M. | +14

10

Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC

enthalten in: Targeted oncology | 2021

von Wei, J. | Meng, P. | Terpstra, M. | +14